Literature DB >> 21830075

Pharmacist prescribing in Northern Ireland: a quantitative assessment.

Laura McCann1, Sharon Haughey, Carole Parsons, Fran Lloyd, Grainne Crealey, Gerard J Gormley, Carmel M Hughes.   

Abstract

OBJECTIVE: Health care in the United Kingdom (UK) has undergone a significant change in terms of the range of professionals who are permitted to prescribe medications. This study aimed to capture information on pharmacist prescribing in Northern Ireland (NI).
SETTING: Primary and secondary care in NI.
METHOD: A structured self-administered questionnaire was developed and sent to all pharmacists who were identified as qualified prescribers in NI (n = 105), although only 100 respondents provided details of their prescribing status i.e. currently prescribing, previous prescribers and those who had never prescribed. Three versions of the questionnaire were developed to accommodate each category of prescriber. The questionnaire, which sought information on clinical areas/practice settings of prescribers, their working arrangements and barriers to prescribing was distributed by mail on two occasions to maximise response rates. Descriptive analyses were used as appropriate, together with Chi-squared tests or Fisher exact tests to evaluate associations between responses and demographic information, with significance set a priori at P < 0.05. Qualitative data (from the free text response section) were analysed for recurring themes using content analysis.
RESULTS: A response rate of 76.0% (n = 76) was achieved. There were more female respondents (73.7%) than males (26.3%). Nearly 50% of respondents were currently prescribing (n = 36; 47.4%), 46.1% (n = 35) had never prescribed and 6.6% (n = 5) had prescribed in the past. There were perceived benefits in terms of patient care and perception of the pharmacist within the health care team. A number of barriers to pharmacist prescribing were reported. Independent prescribing was viewed as the way forward, although pharmacists expressed reluctance to prescribe without a diagnosis or beyond the team setting.
CONCLUSION: Pharmacy prescribing has yet to fully embedded in routine practice. This study has shown that the number of qualified prescribers in NI is relatively small and not all have taken up prescribing responsibilities. Well recognised barriers were reported as reasons as to why qualified prescribers were unable to use their prescribing skills. Further research should provide an in-depth understanding of pharmacy prescribing in NI and examine patients' experiences of this form of practice.

Entities:  

Mesh:

Year:  2011        PMID: 21830075     DOI: 10.1007/s11096-011-9545-7

Source DB:  PubMed          Journal:  Int J Clin Pharm


  7 in total

1.  'It's showed me the skills that he has': pharmacists' and mentors' views on pharmacist supplementary prescribing.

Authors:  Fran Lloyd; Carole Parsons; Carmel M Hughes
Journal:  Int J Pharm Pract       Date:  2010-02

2.  Attitudes towards, and information needs in relation to, supplementary nurse prescribing in the UK: an empirical study.

Authors:  Dianne Berry; Molly Courtenay; Elisabetta Bersellini
Journal:  J Clin Nurs       Date:  2006-01       Impact factor: 3.036

3.  Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006.

Authors:  L Guillaume; R Cooper; A Avery; S Mitchell; P Ward; C Anderson; P Bissell; A Hutchinson; V James; J Lymn; A McIntosh; E Murphy; J Ratcliffe
Journal:  J Clin Pharm Ther       Date:  2008-02       Impact factor: 2.512

4.  Supplementary prescribing: early experiences of pharmacists in Great Britain.

Authors:  Johnson George; Dorothy J McCaig; Christine M Bond; I T Scott Cunningham; H Lesley Diack; Anne M Watson; Derek C Stewart
Journal:  Ann Pharmacother       Date:  2006-09-12       Impact factor: 3.154

5.  Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service.

Authors:  Derek C Stewart; Katie Maclure; Christine M Bond; Scott Cunningham; Lesley Diack; Johnson George; Dorothy J McCaig
Journal:  Int J Pharm Pract       Date:  2011-06-09

6.  The changing nature of prescribing: pharmacists as prescribers and challenges to medical dominance.

Authors:  Marjorie C Weiss; Jane Sutton
Journal:  Sociol Health Illn       Date:  2008-12-03

Review 7.  Nurse and pharmacist supplementary prescribing in the UK--a thematic review of the literature.

Authors:  Richard Jason Cooper; Claire Anderson; Tony Avery; Paul Bissell; Louise Guillaume; Allen Hutchinson; Veronica James; Joanne Lymn; Aileen McIntosh; Elizabeth Murphy; Julie Ratcliffe; Sue Read; Paul Ward
Journal:  Health Policy       Date:  2007-09-27       Impact factor: 2.980

  7 in total
  6 in total

1.  Stakeholders' views and experiences of pharmacist prescribing: a systematic review.

Authors:  Tesnime Jebara; Scott Cunningham; Katie MacLure; Ahmed Awaisu; Abdulrouf Pallivalapila; Derek Stewart
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

2.  A patient perspective of pharmacist prescribing: 'crossing the specialisms-crossing the illnesses'.

Authors:  Laura M McCann; Sharon L Haughey; Carole Parsons; Fran Lloyd; Grainne Crealey; Gerard J Gormley; Carmel M Hughes
Journal:  Health Expect       Date:  2012-10-15       Impact factor: 3.377

3.  Rounding of birth weights in a neonatal intensive care unit over 20 years: an analysis of a large cohort study.

Authors:  Anthony J Emmerson; Stephen A Roberts
Journal:  BMJ Open       Date:  2013-12-05       Impact factor: 2.692

Review 4.  Facilitators and barriers to non-medical prescribing - A systematic review and thematic synthesis.

Authors:  Emma Graham-Clarke; Alison Rushton; Timothy Noblet; John Marriott
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

5.  General practitioners' experiences with, views of, and attitudes towards, general practice-based pharmacists: a cross-sectional survey.

Authors:  Ameerah S Hasan Ibrahim; Heather E Barry; Carmel M Hughes
Journal:  BMC Prim Care       Date:  2022-01-14

6.  Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.

Authors:  Laura V Minard; Heidi Deal; Megan E Harrison; Kent Toombs; Heather Neville; Andrea Meade
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.